PATENT CLAIM ANALYSIS

Application Number: 15753033
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "456000"]

Abstract:
The present invention provides compositions and methods for the treatment or prevention of pulmonary hypertension comprising administering an ascomycin, or a pharmaceutically acceptable salt, solvate, analog, or prodrug thereof to the patient with pulmonary hypertension. Described herein are liquid formulations which deliver an ascomycin. The liquid formulation can be placed in a soft gelatin capsule.

Claim (Index 4):
The soft gelatin capsule of  claim 1 , wherein the active agent is tacrolimus, ascomycin, desmethyl ascomycin, or prolyltacrolimus.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.31915
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10631143', '11293747', '11293286', '09738212', '15524174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.718428855993656
- 35 USC 102 Novelty (BERT): 0.4765315394232562
- Combined Prediction Score: 0.694239124336616
- Mean Citation Score: 144.00863400000003
- Max Citation Score: 161.63193
- Similarity Product: 116.93604065035343

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test